V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009293 | 190006148 | 1.48 | null | null | 2018-08-17 | 2018-08-31 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101577436 |
| 190009313 | 190006149 | 1.76 | 60.8 | Curative (C) | 2020-06-19 | 2020-06-24 | CARBOPLATIN + PACLITAXEL | 01 | N | CARBOPLATIN + PACLITAXEL | 100069593 |
| 190009315 | 190006150 | 1.73 | 49 | Adjuvant (A) | 2021-05-18 | 2021-05-25 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + RT | 100987342 |
| 190009322 | 190006151 | 1.82 | 79.7 | Palliative (P) | 2018-05-08 | 2018-05-28 | EW EuroEwing 2012 Arm B VDC/IE | N | N | CAPECITABINE + IRINOTECAN | 100420074 |
| 190009326 | 190006152 | 0 | 17.1 | null | 2016-12-14 | 2017-06-16 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 100858772 |
| 190009329 | 190006153 | 1.63 | 49.7 | null | 2019-06-25 | 2019-06-25 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + OXALIPLATIN | 100062057 |
| 190009332 | 190006154 | 1.67 | 59.2 | Palliative (P) | 2020-08-04 | 2020-08-05 | Cisplatin 7 day | 02 | N | CISPLATIN | 100433526 |
| 190009340 | 190006155 | null | 56.7 | Curative (C) | 2021-08-06 | 2021-11-28 | CARBOPLATIN + ETOPOSIDE | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101125216 |
| 190009351 | 190006156 | 1.64 | 95 | Curative (C) | 2018-12-21 | 2019-01-24 | Bevacizumab 7.5mg/kg | 02 | null | CISPLATIN + GEMCITABINE | 100077163 |
| 190009357 | 190006157 | 1.62 | 89.3 | Neo-adjuvant (N) | 2018-09-29 | 2019-05-19 | Cyclophosphamide + Vincristine | 02 | N | CARBOPLATIN + GEMCITABINE | 101866940 |
| 190009359 | 190006158 | 1.14 | 26.8 | Curative (C) | 2018-01-04 | 2018-01-29 | EOX | 02 | null | LANREOTIDE | 100505515 |
| 190009360 | 190006159 | 0 | 69.6 | Neo-adjuvant (N) | 2019-12-03 | 2020-01-04 | EW EuroEwing 2012 Arm A VAI | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101313484 |
| 190009362 | 190006160 | 0 | 24.6 | null | 2019-06-08 | 2019-06-09 | OST Mifamurtide | null | Y | CARBOPLATIN + GEMCITABINE | 101698984 |
| 190009365 | 190006161 | 0 | 72.6 | Palliative (P) | 2015-08-24 | 2015-09-21 | Cisplatin 100 + RT(H&N) 1 day | null | null | CISPLATIN | 101285967 |
| 190009370 | 190006162 | 1.61 | 77.9 | Curative (C) | 2018-07-17 | 2018-07-30 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | null | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100310839 |
| 190009375 | 190006163 | 1.58 | 35 | Palliative (P) | 2021-02-28 | 2021-03-01 | DHAP | Y | N | CYTARABINE | 101571506 |
| 190009383 | 190006164 | 1.66 | 94 | Neo-adjuvant (N) | 2021-02-14 | 2021-03-03 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101263645 |
| 190009391 | 190006165 | 0 | 33.4 | Curative (C) | null | 2021-05-03 | Etoposide oral | 02 | null | NIRAPARIB | 100856565 |
| 190009394 | 190006166 | 1.72 | 69.4 | Palliative (P) | 2020-02-11 | 2020-02-11 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 101428911 |
| 190009396 | 190006167 | 1.6 | 63.2 | null | 2019-06-15 | 2019-06-26 | DHAP | 02 | Y | TRIAL | 101470043 |
| 190009397 | 190006168 | 1.74 | 41.4 | Neo-adjuvant (N) | 2015-05-11 | 2016-11-26 | PAM x 2 pre-surgery (cycles 1&2) | 2 | null | OST MIFAMURTIDE | 100097636 |
| 190009405 | 190006169 | 1.74 | 55.75 | 03 | 2019-01-29 | 2019-01-29 | Paclitaxel 7 day | 02 | null | EURO-EWING | 101728198 |
| 190009413 | 190006171 | 0 | 84 | null | 2017-08-21 | 2018-05-12 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101511972 |
| 190009415 | 190006172 | 1.6 | 56.4 | Curative (C) | 2019-06-26 | 2019-07-03 | METHOTREXATE | null | null | METHOTREXATE | 100285785 |
| 190009416 | 190006173 | 0 | 59.4 | Palliative (P) | 2018-07-19 | 2018-07-24 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101804731 |
| 190009428 | 190006174 | 1.68 | 70.9 | null | 2021-11-02 | 2021-11-02 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 101159450 |
| 190009436 | 190006175 | 1.83 | 31.9 | Curative (C) | 2019-04-01 | 2019-04-10 | CNS ATRT Methotrexate Intrathecal | 02 | N | GEMCITABINE | 101506781 |
| 190009440 | 190006176 | 1.74 | 83.4 | Curative (C) | 2018-06-01 | 2018-06-21 | METHOTREXATE | 02 | N | METHOTREXATE | 100102281 |
| 190009449 | 190006177 | 0 | 62 | Palliative (P) | 2020-12-01 | 2020-12-15 | DOCETAXEL + GEMCITABINE | N | N | DOCETAXEL + GEMCITABINE | 101848028 |
| 190009459 | 190006178 | 0 | 62.5 | Curative (C) | 2018-07-13 | 2018-07-17 | Methotrexate High Dose (3g/m2) | 1 | Y | METHOTREXATE | 101373999 |
| 190009469 | 190006179 | null | 66.45 | Palliative (P) | 2018-05-07 | 2018-05-12 | EW EuroEwing 2012 Arm A VAI | 02 | N | EW EUROEWING 2012 ARM A VAI | 100346219 |
| 190009473 | 190006180 | 1.47 | 95.5 | Palliative (P) | 2020-10-05 | 2020-10-10 | VAI (Ifos 3g/m2) | 01 | N | DHAP | 100708468 |
| 190009475 | 190006181 | 1.82 | 62.4 | Curative (C) | 2016-07-28 | 2016-08-11 | Dinutuximab Beta | 02 | null | DOXORUBICIN + METHOTREXATE | 101755166 |
| 190009496 | 190006182 | 1.66 | 93 | Palliative (P) | 2018-06-10 | 2018-06-15 | NIVOLUMAB | 02 | N | TRIAL | 100798783 |
| 190009503 | 190006183 | 0 | 51.3 | null | 2020-02-10 | 2020-02-11 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100485177 |
| 190009505 | 190006184 | 1.45 | 90 | Neo-adjuvant (N) | 2018-10-23 | 2018-10-23 | Capecitabine + Oxaliplatin 21day | 02 | N | ETOPOSIDE | 100154257 |
| 190009511 | 190006185 | 0 | 21 | Neo-adjuvant (N) | 2018-06-06 | 2018-06-25 | MAP + MIFAMURTIDE | 02 | N | EURAMOS TRIAL | 101066893 |
| 190009512 | 190006186 | 1.67 | 56.9 | null | 2018-04-20 | 2018-06-26 | Gemcitabine + Oxaliplatin | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101738123 |
| 190009516 | 190006187 | 1.52 | 64.8 | Palliative (P) | 2021-07-18 | 2021-07-29 | EURAMOS TRIAL | null | Y | EW EUROEWING 2012 ARM B VDC/IE | 101835370 |
| 190009517 | 190006188 | 0 | 0 | Palliative (P) | 2017-12-19 | 2018-01-08 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101378397 |
| 190009519 | 190006189 | 1.68 | 77.1 | null | 2018-07-30 | 2018-08-12 | Methotrexate Intermed dose (1g/m2) | N | N | METHOTREXATE | 101706024 |
| 190009522 | 190006190 | 1.6 | 59.2 | Curative (C) | 2019-12-29 | 2020-07-26 | Docetaxel+Gemcitabine (no prior RT) | 01 | Y | DOCETAXEL + GEMCITABINE | 101045682 |
| 190009532 | 190006191 | 1.93 | 89.8 | Palliative (P) | 2016-04-20 | 2016-09-28 | EW EuroEwing 2012 Arm B IE | Y | N | EW EUROEWING 2012 ARM B IE | 100808837 |
| 190009534 | 190006192 | null | 45.1 | null | 2018-04-01 | 2019-10-03 | Doxorubicin + Olaratumab | 01 | N | MAP | 100158036 |
| 190009543 | 190006193 | 0 | 24.4 | Curative (C) | 2016-06-25 | 2020-04-08 | Cisplatin + Doxorubicin | 02 | N | DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 101218469 |
| 190009544 | 190006194 | 1.71 | 69 | null | 2018-04-05 | 2018-09-22 | NB BEACON Temoz Irin Bev | 02 | null | EURAMOS TRIAL | 100979755 |
| 190009547 | 190006195 | 1.58 | 86.8 | null | 2017-12-03 | 2018-01-06 | Trabectedin | N | Y | CAPECITABINE + CARBOPLATIN | 101582623 |
| 190009561 | 190006197 | 0 | 36 | 03 | 2020-06-14 | 2020-06-19 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101277746 |
| 190009566 | 190006198 | 1.61 | 42.8 | Adjuvant (A) | 2019-07-23 | 2019-10-20 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100417776 |
| 190009570 | 190006199 | 1.82 | 49.8 | Neo-adjuvant (N) | 2021-04-07 | 2021-04-13 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100245391 |